SP16 as a Therapeutic for COVID-19 Induced ARDS
Clinical trial NCT05135624 · TERMINATED
Trial details
- NCT number
- NCT05135624
- Sponsor
- Serpin Pharma, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-06-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.